Please login to the form below

Not currently logged in
Email:
Password:

tardive dyskinesia

This page shows the latest tardive dyskinesia news and features for those working in and with pharma, biotech and healthcare.

FDA clears Teva's tardive dyskinesia drug Austedo

FDA clears Teva's tardive dyskinesia drug Austedo

FDA clears Teva's tardive dyskinesia drug Austedo. The twice-daily drug will compete with Neurocrine Bioscience’s Ingrezza. ... April. Tardive dyskinesia, a neurological disorder characterised by repetitive involuntary movements such as grimacing,

Latest news

More from news
Approximately 7 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics